Revelation Biosciences, Inc. (REVB)
1.01
0.00 (0.00%)
USD |
NASDAQ |
Sep 09, 12:06
Revelation Biosciences Total Liabilities (Quarterly) : 2.431M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.431M |
| March 31, 2026 | 2.055M |
| December 31, 2025 | 2.722M |
| September 30, 2025 | 1.854M |
| June 30, 2025 | 1.569M |
| March 31, 2025 | 1.090M |
| December 31, 2024 | 1.914M |
| September 30, 2024 | 4.066M |
| June 30, 2024 | 11.13M |
| March 31, 2024 | 5.228M |
| December 31, 2023 | 5.565M |
| September 30, 2023 | 5.40M |
| June 30, 2023 | 4.624M |
| March 31, 2023 | 8.101M |
| Date | Value |
|---|---|
| December 31, 2022 | 4.451M |
| September 30, 2022 | 4.374M |
| June 30, 2022 | 5.997M |
| March 31, 2022 | 8.078M |
| December 31, 2021 | 2.142M |
| September 30, 2021 | 6.649M |
| June 30, 2021 | 6.224M |
| March 31, 2021 | 5.032M |
| December 31, 2020 | 6.345M |
| September 30, 2020 | 3.486M |
| June 30, 2020 | 0.0793M |
| March 31, 2020 | |
| December 31, 2019 | 0.0263M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Shuttle Pharmaceuticals Holdings, Inc. | 8.463M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Agenus, Inc. | 378.54M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Amgen, Inc. | 83.95B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.50M |
| Shareholders Equity (Quarterly) | 10.07M |
| Debt to Equity Ratio | 0.0735 |
| Current Ratio | 6.214 |
| Net Debt Paydown Yield | -3.68% |